<!--
title: An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) in a secondary care hospital in Finland, May 2021
description: https://doi.org/10.2807/1560-7917.ES.2021.26.30.2100636
published: true
date: 2022-01-10T11:37:08.794Z
tags: #vaccine, #sarscov2, #breakthrough, #infections, #hospital, #delta, #vaccination, #outbreak, #ppe, #alpha
editor: ckeditor
dateCreated: 2022-01-10T11:36:17.371Z
-->

<h1>An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) in a secondary care hospital in Finland, May 2021&nbsp;</h1>
<p>&nbsp;</p>
<p><a href="https://www.eurosurveillance.org/search?value1=Iivo+Hetem%C3%A4ki&amp;option1=author&amp;noRedirect=true">Iivo Hetemäki</a><sup>1,2</sup> , <a href="https://www.eurosurveillance.org/search?value1=Sohvi+K%C3%A4%C3%A4ri%C3%A4inen&amp;option1=author&amp;noRedirect=true">Sohvi Kääriäinen</a><sup>3,4</sup> , <a href="https://www.eurosurveillance.org/search?value1=Pirjo+Alho&amp;option1=author&amp;noRedirect=true">Pirjo Alho</a><sup>1</sup> , <a href="https://www.eurosurveillance.org/search?value1=Janne+Mikkola&amp;option1=author&amp;noRedirect=true">Janne Mikkola</a><sup>1</sup> , <a href="https://www.eurosurveillance.org/search?value1=Carita+Savolainen-Kopra&amp;option1=author&amp;noRedirect=true">Carita Savolainen-Kopra</a><sup>4</sup> , <a href="https://www.eurosurveillance.org/search?value1=Niina+Ikonen&amp;option1=author&amp;noRedirect=true">Niina Ikonen</a><sup>4</sup> , <a href="https://www.eurosurveillance.org/search?value1=Hanna+Nohynek&amp;option1=author&amp;noRedirect=true">Hanna Nohynek</a><sup>4</sup> , <a href="https://www.eurosurveillance.org/search?value1=Outi+Lyytik%C3%A4inen&amp;option1=author&amp;noRedirect=true">Outi Lyytikäinen</a><sup>4</sup></p>
<p><a href="https://www.eurosurveillance.org/search?value1=Iivo+Hetem%C3%A4ki&amp;option1=author&amp;noRedirect=true">Hetemäki Iivo</a>, <a href="https://www.eurosurveillance.org/search?value1=Sohvi+K%C3%A4%C3%A4ri%C3%A4inen&amp;option1=author&amp;noRedirect=true">Kääriäinen Sohvi</a>, <a href="https://www.eurosurveillance.org/search?value1=Pirjo+Alho&amp;option1=author&amp;noRedirect=true">Alho Pirjo</a>, <a href="https://www.eurosurveillance.org/search?value1=Janne+Mikkola&amp;option1=author&amp;noRedirect=true">Mikkola Janne</a>, <a href="https://www.eurosurveillance.org/search?value1=Carita+Savolainen-Kopra&amp;option1=author&amp;noRedirect=true">Savolainen-Kopra Carita</a>, <a href="https://www.eurosurveillance.org/search?value1=Niina+Ikonen&amp;option1=author&amp;noRedirect=true">Ikonen Niina</a>, <a href="https://www.eurosurveillance.org/search?value1=Hanna+Nohynek&amp;option1=author&amp;noRedirect=true">Nohynek Hanna</a>, <a href="https://www.eurosurveillance.org/search?value1=Outi+Lyytik%C3%A4inen&amp;option1=author&amp;noRedirect=true">Lyytikäinen Outi</a>. An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) in a secondary care hospital in Finland, May 2021. <a href="https://www.eurosurveillance.org/content/ecdc">Euro Surveill.</a> 2021;26(30):pii=2100636. <a href="https://doi.org/10.2807/1560-7917.ES.2021.26.30.2100636">https://doi.org/10.2807/1560-7917.ES.2021.26.30.2100636</a>Received: 28 Jun 2021;&nbsp;&nbsp; Accepted: 28 Jul 2021</p>
<p>&nbsp;</p>
<p>The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant of concern (Phylogenetic Assignment of Named Global Outbreak (Pango) lineage designation B.1.617.2) has been suggested to be more transmissible than the Alpha (B.1.1.7) variant [<a href="https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2021.26.30.2100636#r1">1</a>], which is more transmissible than the wild-type SARS-CoV-2 virus [<a href="https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2021.26.30.2100636#r2">2</a>-<a href="https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2021.26.30.2100636#r4">4</a>]. We describe here an outbreak caused by the Delta variant that originated from one inpatient in a secondary care hospital and spread within the hospital and to three primary care facilities; we describe our experiences in controlling it. Cases were detected among patients, healthcare workers (HCW) and in the community. Both symptomatic and asymptomatic infections were found among vaccinated HCW, and secondary transmission occurred from those with symptomatic infections despite use of personal protective equipment (PPE).</p>
<p>&nbsp;</p>
<p>Source: https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2021.26.30.2100636</p>
<p>&nbsp;</p>
